This Viewpoint outlines new priorities of the US Food and Drug Administration (FDA).
Home | JAMA | New Online
Viewpoint
Priorities for a New FDA
Martin A. Makary, MD, MPH1; Vinay Prasad, MD, MPH1
Author Affiliations Article Information
Leaders of the FDA have published a list of new priorities for the agency. They want to deliver rapidly-approved cures and…
What Marty Makary's successor can learn from his mistakes.
As leadership changes create more instability at the FDA, here’s what one former agency official thinks it will take to keep…
Experts clash over significance of agency's reversals on certain rare disease drugs
Makary helms the FDA in the midst of a contentious stretch for the agency, defined by massive staff and budget cuts and sweeping…
Marty Makary is out, and experts are calling for a return to order
